Open AccessComparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>
Author(s) -
Stuart J. Connolly
Publication year - 2006
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.295.2.165
Subject(s) - sotalol , medicine , amiodarone , beta blocker , cardiology , antiarrhythmic agent , randomized controlled trial , anesthesia , implantable cardioverter defibrillator , hazard ratio , shock (circulatory) , atrial fibrillation , confidence interval , heart failure , heart disease
Implantable cardioverter defibrillator (ICD) therapy is effective but is associated with high-voltage shocks that are painful.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom